Latest data from Stryker with Mark Paul at LINNC Paris 2022

Bringing together specialists from throughout the world, join Mark Paul, President of Stryker Neurovascular, as he returns to LINNC Paris 2022 to lead his team in support of their well-known quality devices such as Surpass Evolve and Trevo as well as announcing innovative programs and trials from the latest ASSIST registry data to StrokEnomics and BRAINOMIX – all in the service of our patients and the doctors who treat them.

INTERVIEW

A powerful dedicated tool for effective flow diversion – the Surpass Evolve from Stryker

INTERVIEW

BRAINOMIX: What is it? And what can it do for you to increase stroke care coverage?

INTERVIEW

Supporting operator choice in Stroke treatment: the ASSIST Registry compares 3 different techniques

INTERVIEW

Dedicated to the doctors and the patients they treat – Latest data from the ASSIST Registry and experience with BRAINOMIX

INTERVIEW

Long Term Results for the Treatment of Intracranial Aneurysms With the Surpass Evolve Flow Diverter: a Multicenter Experience